Cardiocast

Societies refresh diabetes and PAD guidance


 

This week, the barbershop may become a key battleground in the fight against hypertension, the American Diabetes Association upgrades newer antihyperglycemics, refreshed appropriate use criteria for peripheral artery disease are released, and body mass index as a measure of cardiometabolic risk gets a boost.

Subscribe to Cardiocast wherever you get your podcasts.

Amazon Alexa

Apple Podcasts

Recommended Reading

Empagliflozin reduces left ventricular mass
MDedge Endocrinology
CAC scores in type 1 diabetes no higher than general population
MDedge Endocrinology
‘Phenomenal’ REDUCE-IT establishes triglyceride theory
MDedge Endocrinology
Healthier lifestyle in midlife women reduces subclinical carotid atherosclerosis
MDedge Endocrinology
Combined novel risk factors raise coronary event rates
MDedge Endocrinology
AHA: Statins associated with high degree of safety
MDedge Endocrinology
CABG surpasses PCI for diabetics out to 7.5 years
MDedge Endocrinology
AHA statement on statin risks, app that diagnoses STEMI, and more
MDedge Endocrinology
Real-world weight loss with meds approximates RCT results
MDedge Endocrinology
Opioids don’t top NSAIDs for chronic pain
MDedge Endocrinology